Development of the Industrial Process to Manufacture a Highly Potent Active Pharmaceutical Ingredient

Abstract

Commercializing new drugs is an extremely costly and time-consuming investment for a pharmaceutical company. The optimization of drug manufacturing has become critical for the commercial success of these high added-value products. The scope of this project is the development of a manufacturing process to commercial scale of a well-known API to be sold as a generic._x000D_ _x000D_ With the pass of the years, the pharmaceutical industry has developed more and more targeted therapies. Regarding small molecules, the active pharmaceutical ingredients (APIs) that show a very highly selectivity for its pharmacological target and exhibit a biological activity at extremely low concentrations, are known as Highly Potent APIs (HPAPIs).

Date of Award	24 Jul 2024
Original language	English
Supervisor	Juan Pablo Bayon Rueda (Director)